Treatment of End-Stage Renal Failure in Hong Kong

2015 ◽  
pp. 25-30 ◽  
Author(s):  
M. K. Chan
Keyword(s):  
Renal Failure ◽  
Hong Kong ◽  
End Stage Renal Failure ◽  
End Stage

scholarly journals Peritoneal Dialysis in Asia

2015 ◽  
Vol 1 (3) ◽  
pp. 147-156 ◽  
Author(s):  
Vickie Wai-Ki Kwong ◽  
Philip Kam-Tao Li
Keyword(s):  
Renal Failure ◽  
Hong Kong ◽  
Peritoneal Dialysis ◽  
Rural Areas ◽  
Cost Effective ◽  
Asian Countries ◽  
End Stage Renal Failure ◽  
East And West ◽  
End Stage

Background: There is a growing demand of dialysis in Asia for end-stage renal failure patients. Diabetes mellitus is the leading cause of end-stage renal failure in many countries in Asia. Summary: The growth of peritoneal dialysis (PD) in Asia is significant and seeing a good trend. With the enhanced practices of PD, the quality of care in PD in Asia is also improved. Overall, PD and hemodialysis (HD) are comparable in clinical outcome. There is a global trend in the reduction of peritonitis rates and Asian countries also witness such improvement. The socio-economic benefits of PD for end-stage renal failure patients in both urban and rural areas in the developed and developing regions of Asia are an important consideration. This can help to reduce the financial burden of renal failure in addressing the growing demand of patients on dialysis. Initiatives should be considered to further drive down the cost of PD in Asia. Key Messages: Growing demand for dialysis by an increasing number of end-stage renal failure patients requires the use of a cost-effective quality dialysis modality. PD is found to be comparable to HD in outcome and quality. In most countries in Asia, PD should be more cost-effective than HD. A ‘PD-first' or a ‘PD as first considered therapy' policy can be an overall strategy in many countries in Asia in managing renal failure patients, taking the examples of Hong Kong and Thailand. Facts from East and West: (1) PD is cheaper than HD and provides a better quality of life worldwide, but its prevalence is significantly lower than that of HD in all countries, with the exception of Hong Kong. Allowing reimbursement of PD but not HD has permitted to increase the use of PD over HD in many Asian countries like Hong Kong, Vietnam, Taiwan, Thailand, as well as in New Zealand and Australia over the last years. In the Western world, however, HD is still promoted, and the proportion of patients treated with PD decreases. Japan remains an exception in Asia where PD penetration is very low. Lack of adequate education of practitioners and information of patients might as well be reasons for the low penetration of PD in both the East and West. (2) Patient survival of PD varies between and within countries but is globally similar to HD. (3) Peritonitis remains the main cause of morbidity in PD patients. South Asian countries face specific issues such as high tuberculosis and mycobacterial infections, which are rare in developed Asian and Western countries. The infection rate is affected by climatic and socio-economic factors and is higher in hot, humid and rural areas. (4) Nevertheless, the promotion of a PD-first policy might be beneficial particularly for remote populations in emerging countries where the end-stage renal disease rate is increasing dramatically.

DYSPEPSIA SYNDROME AND HELICOBACTER PYLORI INFECTION IN END STAGE RENAL FAILURE

2000 ◽  
Vol 15 (12) ◽  
pp. H2-H2
Author(s):  
IS Mertasudira ◽  
JR Saketi ◽  
A. Djumhana ◽  
J. Widjojo ◽  
SA Abdurachman
Keyword(s):  
Renal Failure ◽  
Helicobacter Pylori ◽  
Helicobacter Pylori Infection ◽  
End Stage Renal Failure ◽  
End Stage

A risk assessment score for patients with end-stage renal failure undergoing cardiac surgery

2006 ◽  
Vol 54 (S 1) ◽  
Author(s):  
T Krabatsch ◽  
M Bechtel ◽  
C Detter ◽  
T Fischlein ◽  
FC Riess ◽  
...  
Keyword(s):  
Risk Assessment ◽  
Renal Failure ◽  
Cardiac Surgery ◽  
End Stage Renal Failure ◽  
Assessment Score ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document